Skip to main content
. 2023 Aug 17;14:1195247. doi: 10.3389/fendo.2023.1195247

Table 3.

Absolute plasma fatty acids of the study.

Fatty Acid
(μg/ml)
Total TG (<1.7) TG (≥1.7) p
n=40 n=18 n=22
14:0 33.29 ± 2.56 28.93 ± 2.21 37.02 ± 2.85 0.21
16:0 585.78 ± 33.03 528.7 ± 22.14 634.7 ± 42.36 0.04
16:1n-7 49.12 ± 5.18 41.01 ± 4.16 56.07 ± 6.05 0.05
18:0 144.22 ± 7.89 136.3 ± 5.74 151 ± 9.73 0.22
18:1n-9 326.61 ± 13.61 304.1 ± 10.43 345.9 ± 16.33 0.04
C18:1n-7 31.54 ± 2.28 30.11 ± 2.11 32.76 ± 2.43 0.42
18:2n-6 (LA) 315.04 ± 19.48 311 ± 12.86 318.5 ± 25.16 0.80
20:0 5.14 ± 0.32 5.62 ± 0.36 4.73 ± 0.29 0.06
18:3n-6 7.09 ± 0.5 7.33 ± 0.5 6.89 ± 0.5 0.54
18:3n-3 8.26 ± 0.64 7.69 ± 0.49 8.75 ± 0.77 0.27
20:1n-9 3.48 ± 0.17 4.02 ± 0.2 3.03 ± 0.15 < 0.01
20:2n-6 3.53 ± 0.17 3.85 ± 0.18 3.25 ± 0.16 0.02
22:0 7.52 ± 0.38 7.86 ± 0.33 7.22 ± 0.41 0.24
20:3n-6 23.55 ± 1.34 21.99 ± 1.53 24.89 ± 1.19 0.14
20:4n-6 (AA) 98.75 ± 5.95 95.3 ± 5.99 101.7 ± 5.91 0.45
20:5n-3 (EPA) 11.5 ± 2 9.67 ± 0.91 13.08 ± 2.95 0.31
24:0 4.02 ± 0.29 4.27 ± 0.35 3.8 ± 0.24 0.35
24:1n-9 7.52 ± 0.49 8.08 ± 0.53 7.04 ± 0.46 0.15
22:4n-6 4.69 ± 0.32 5.02 ± 0.44 4.41 ± 0.22 0.21
C22:5n-6 3.07 ± 0.15 3.37 ± 0.17 2.81 ± 0.14 0.01
22:5n-3 (DPA) 6.45 ± 0.54 7.29 ± 0.44 5.72 ± 0.62 0.05
22:6n-3 (DHA) 22.22 ± 2.9 17.89 ± 1.27 25.93 ± 4.31 0.10
SFA 779.98 ± 41.43 711.7 ± 28.49 838.5 ± 52.52 0.53
MUFA 418.26 ± 18.44 387.3 ± 14.46 444.8 ± 21.86 0.04
PUFA 504.18 ± 25.8 490.4 ± 14.82 516 ± 35.22 0.53
n-6 PUFA 455.76 ± 22.05 447.9 ± 14.01 462.5 ± 28.94 0.67
n-3 PUFA 48.43 ± 5.14 42.53 ± 1.45 53.49 ± 8.3 0.24
n-6/n-3 10.23 ± 0.49 10.63 ± 0.34 9.89 ± 0.62 0.32
EPA + DHA 33.72 ± 4.52 27.55 ± 1.4 39.01 ± 7.19 0.11

Data are presented as mean ± SEM; p values are based on t-test or Mann-Whitney test, and p < 0.05 was considered statistically significant; LA, linoleic acid; AA, arachidonic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid; SFA, saturated fatty acids; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.